Gut microbiome composition to predict resistance in renal cell carcinoma (RCC) patients on nivolumab.

4519Background: Efforts are ongoing to identify mechanisms driving response/resistance to immune checkpoint inhibitors (ICI) in order to personalize therapy. Recently, we speculated that antibiotic...